Aion Therapeutic Inc. (CSE:AION)
Canada · Delayed Price · Currency is CAD 0.0050
0.00 (0.00%)
Inactive · Last trade price on Sep 5, 2025
Aion Therapeutic Balance Sheet
Financials in millions CAD. Fiscal year is May - April.
Millions CAD. Fiscal year is May - Apr.
Assets
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Jan '25 Jan 31, 2025 | Apr '24 Apr 30, 2024 | Apr '23 Apr 30, 2023 | Apr '22 Apr 30, 2022 | Apr '21 Apr 30, 2021 | Apr '20 Apr 30, 2020 |
Cash & Equivalents | 0.01 | 0.07 | 0 | - | 0.24 | 0.61 |
Cash & Short-Term Investments | 0.01 | 0.07 | 0 | - | 0.24 | 0.61 |
Cash Growth | -96.04% | 20238.10% | - | - | -60.86% | -62.24% |
Accounts Receivable | 0.14 | 0 | - | - | - | - |
Other Receivables | 0.02 | 0.05 | 0.2 | 0.14 | - | 0.07 |
Receivables | 0.16 | 0.05 | 0.2 | 0.14 | - | 0.07 |
Inventory | 0.41 | 0.4 | - | - | - | - |
Prepaid Expenses | 0.54 | 0.01 | - | 0.01 | 0.22 | 0.04 |
Other Current Assets | - | - | - | - | 0.02 | 0.02 |
Total Current Assets | 1.12 | 0.53 | 0.2 | 0.15 | 0.47 | 0.75 |
Property, Plant & Equipment | 0.09 | 0.17 | - | - | 0.56 | 2.53 |
Long-Term Investments | - | - | 0.01 | - | - | - |
Other Long-Term Assets | - | - | - | - | 0.57 | 0.06 |
Total Assets | 1.21 | 0.7 | 0.21 | 0.15 | 1.6 | 3.34 |
Liabilities
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Jan '25 Jan 31, 2025 | Apr '24 Apr 30, 2024 | Apr '23 Apr 30, 2023 | Apr '22 Apr 30, 2022 | Apr '21 Apr 30, 2021 | Apr '20 Apr 30, 2020 |
Accounts Payable | 2.64 | 2.28 | 1.68 | 1.44 | 0.58 | 0.15 |
Accrued Expenses | 0.21 | 0.22 | 0.28 | 0.37 | 0.01 | 0.06 |
Short-Term Debt | 2.81 | 2.01 | 0.97 | 0.74 | - | - |
Current Portion of Long-Term Debt | - | - | - | - | 0.5 | 0.13 |
Current Portion of Leases | - | 0.07 | - | - | 0.07 | 0.11 |
Other Current Liabilities | 0.22 | - | - | - | 0.05 | 0.03 |
Total Current Liabilities | 5.88 | 4.57 | 2.94 | 2.56 | 1.21 | 0.48 |
Long-Term Debt | - | - | - | - | - | 0.43 |
Long-Term Leases | - | - | - | - | - | 0.3 |
Total Liabilities | 5.88 | 4.57 | 2.94 | 2.56 | 1.21 | 1.2 |
Shareholders' Equity
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Jan '25 Jan 31, 2025 | Apr '24 Apr 30, 2024 | Apr '23 Apr 30, 2023 | Apr '22 Apr 30, 2022 | Apr '21 Apr 30, 2021 | Apr '20 Apr 30, 2020 |
Common Stock | 20.63 | 19.43 | 14.79 | 14.71 | 13.26 | 7.73 |
Additional Paid-In Capital | 0.39 | 0.39 | 0.39 | 0.39 | 0.28 | 0.28 |
Retained Earnings | -27.61 | -26.36 | -20.08 | -19.82 | -16 | -7.74 |
Comprehensive Income & Other | 1.92 | 2.67 | 2.17 | 2.32 | 2.86 | 1.86 |
Shareholders' Equity | -4.67 | -3.87 | -2.73 | -2.41 | 0.4 | 2.13 |
Total Liabilities & Equity | 1.21 | 0.7 | 0.21 | 0.15 | 1.6 | 3.34 |
Additional Metrics
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Jan '25 Jan 31, 2025 | Apr '24 Apr 30, 2024 | Apr '23 Apr 30, 2023 | Apr '22 Apr 30, 2022 | Apr '21 Apr 30, 2021 | Apr '20 Apr 30, 2020 |
Total Debt | 2.81 | 2.08 | 0.97 | 0.74 | 0.57 | 0.96 |
Net Cash (Debt) | -2.8 | -2.01 | -0.97 | -0.74 | -0.33 | -0.35 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share | -0.01 | -0.01 | -0.01 | -0.01 | -0.00 | -0.01 |
Filing Date Shares Outstanding | 497.15 | 497.15 | 190.05 | 147.3 | 141.8 | 74.18 |
Total Common Shares Outstanding | 497.15 | 411.55 | 147.3 | 141.8 | 124.8 | 36.68 |
Working Capital | -4.76 | -4.04 | -2.74 | -2.41 | -0.73 | 0.27 |
Book Value Per Share | -0.01 | -0.01 | -0.02 | -0.02 | 0.00 | 0.06 |
Tangible Book Value | -4.67 | -3.87 | -2.73 | -2.41 | 0.4 | 2.13 |
Tangible Book Value Per Share | -0.01 | -0.01 | -0.02 | -0.02 | 0.00 | 0.06 |
Machinery | - | 0.11 | - | - | 0.5 | 2.01 |
Leasehold Improvements | - | - | - | - | - | 0.14 |